Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | MDM4 | O15151 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MDM2 | Q00987 | 4/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29398713 | 1.00 | TLR2 (0.53) | TLR2KMT2AHDAC1HDAC2MDM4 | |
| SCHEMBL31004028 | 1.00 | TLR2 (0.53) | TLR2KMT2AHDAC1HDAC2MDM4 | |
| SCHEMBL12221104 | 1.00 | TLR2 (0.53) | TLR2KMT2AHDAC1HDAC2MDM4 | |
| Hydrochloric Acid SCHEMBL29217894 | 0.99 | TLR2 (0.54) | TLR2KMT2AHDAC1HDAC2MDM4 | |
| Hydrochloric Acid SCHEMBL30202339 | 0.99 | TLR2 (0.54) | TLR2KMT2AHDAC1HDAC2MDM4 | |
| Hydrochloric Acid SCHEMBL25358748 | 0.99 | TLR2 (0.54) | TLR2KMT2AHDAC1HDAC2MDM4 | |
| Hydrochloric Acid SCHEMBL30003033 | 0.99 | TLR2 (0.54) | TLR2KMT2AHDAC1HDAC2MDM4 | |
| Hydrochloric Acid SCHEMBL25358745 | 0.99 | TLR2 (0.54) | TLR2KMT2AHDAC1HDAC2MDM4 | |
| Hydrochloric Acid SCHEMBL29401186 | 0.99 | TLR2 (0.54) | TLR2KMT2AHDAC1HDAC2MDM4 | |
| SCHEMBL30819043 | 0.97 | TLR2 (0.50) | TLR2KMT2AHDAC1HDAC2MDM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
| US-9295732-B2 | Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists | INVIVOGEN (FR) | 2016-03-29 | — | — | US | disclosed |
| US-9295732-B2 | Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists | INVIVOGEN (FR) | 2016-03-29 | — | — | US | disclosed |
| US-9139862-B2 | Fluorescent cyclic peptides, preparation method thereof and use of these peptides for measuring the enzymatic activity of a protease enzyme | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-09-22 | — | — | US | disclosed |
| US-20140242108-A1 | Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists | CAYLA (FR) | 2014-08-28 | — | — | US | disclosed |
| US-20140242108-A1 | Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists | CAYLA (FR) | 2014-08-28 | — | — | US | disclosed |
| US-20110256567-A1 | FLUORESCENT CYCLIC PEPTIDES, PREPARATION METHOD THEREOF AND USE OF THESE PEPTIDES FOR MEASURING THE ENZYMATIC ACTIVITY OF A PROTEASE ENZYME | UNIVERSITE VICTOR SEGALEN - BORDEAUX 2 (FR) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110256567-A1 | FLUORESCENT CYCLIC PEPTIDES, PREPARATION METHOD THEREOF AND USE OF THESE PEPTIDES FOR MEASURING THE ENZYMATIC ACTIVITY OF A PROTEASE ENZYME | CTRL, PREP, PEPD | TLR2 3301/4885KMT2A 4375/4885HDAC1 2812/4885 |
| US-20140242108-A1 | Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists | TLR7, TLR8, TLR9 | TLR2 6/4885KMT2A 396/4885HDAC1 309/4885 |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | TLR2 4097/4885KMT2A 3415/4885HDAC1 3939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.